Heterocyclic cyclic ethers

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546268, 546283, A61K 3144, C07D40110

Patent

active

053026039

ABSTRACT:
The invention concerns a heterocyclic cyclic ether of the formula I ##STR1## wherein Q is an optionally substituted 6-membered monocyclic or 10-membered bicyclic heterocyclic moiety containing one or two nitrogen atoms;

REFERENCES:
patent: 4567184 (1986-01-01), Musser et al.
patent: 4625034 (1986-11-01), Neiss et al.
patent: 4631287 (1986-12-01), Chakraborty et al.
patent: 4725619 (1988-02-01), Chakraborty et al.
patent: 4728668 (1988-03-01), Chakraborty et al.
patent: 4794188 (1990-04-01), Musser et al.
patent: 4839369 (1989-06-01), Youssefyeh et al.
patent: 4876346 (1989-10-01), Musser et al.
patent: 4918081 (1990-04-01), Huang et al.
patent: 4920130 (1990-04-01), Huang et al.
patent: 4920131 (1990-04-01), Huang et al.
patent: 4920132 (1990-04-01), Huang et al.
patent: 4920133 (1990-04-01), Huang et al.
Musser et al, "Substituted arylmethyl phenyl ethers.1. A novel series of 5-lipoxygenase inhibitors and leukotriene antagonists", J. of Medicinal Chemistry, vol. 30, No. 1, Jan. 1987, pp. 96-104.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Heterocyclic cyclic ethers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic cyclic ethers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic cyclic ethers will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2098907

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.